Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An update from Numinus Wellness ( (TSE:NUMI) ) is now available.
Numinus Wellness said its common shares will be delisted from the Toronto Stock Exchange on April 22, 2026, following a decision by the TSX’s Continued Listing Committee, a move that aligns with prior shareholder authorization and the company’s stated strategic considerations. Because Numinus remains under a cease trade order, the delisting will not change the current non-tradable status of its securities in Canada, and the company will continue to be a reporting issuer in applicable jurisdictions.
The company has applied to list its shares on the Canadian Securities Exchange, with any potential listing contingent on revocation of the cease trade order and meeting the CSE’s listing requirements. Management is prioritizing completion of the audit for the year ended August 31, 2026, satisfying regulatory conditions to lift the trading ban, and advancing the CSE application as part of a plan to restore trading, improve shareholder liquidity and support its next phase of growth.
Spark’s Take on NUMI Stock
According to Spark, TipRanks’ AI Analyst, NUMI is a Neutral.
The overall stock score for Numinus Wellness is primarily impacted by its poor financial performance, characterized by declining revenues and high operating losses. The technical analysis indicates a neutral position with no clear trend, while the valuation is unattractive due to a negative P/E ratio and lack of dividend yield. These factors collectively result in a low overall score, highlighting significant challenges for the company.
To see Spark’s full report on NUMI stock, click here.
More about Numinus Wellness
Numinus Wellness Inc. is a Vancouver-based mental health care company focused on innovative behavioral health treatments, with a particular emphasis on safe, evidence-based psychedelic-assisted therapies. Through clinical services, research and training, it aims to integrate psychedelic-assisted therapies into mainstream practice for conditions such as depression, anxiety, trauma, pain and substance use disorders.
Technical Sentiment Signal: Sell
Current Market Cap: C$13.86M
Learn more about NUMI stock on TipRanks’ Stock Analysis page.